-
EP1338595
European procedure
Extract from the Register of European Patents
EP About this file: EP1338595
| EP1338595 - Xanthine derivatives as DPP-IV inhibitors [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.03.2007 Database last updated on 07.06.2024 | Most recent event Tooltip | 28.11.2008 | Lapse of the patent in a contracting state New state(s): FR | published on 31.12.2008 [2009/01] | Applicant(s) | For all designated states Eisai Co., Ltd. 6-10, Koishikawa 4-chome, Bunkyo-ku Tokyo 112-8088 / JP | [2006/18] |
| Former [2003/35] | For all designated states Eisai Co., Ltd. 6-10, Koishikawa 4-chome, Bunkyo-ku Tokyo 112-8088 / JP | Inventor(s) | 01 /
Yoshikawa, Seiji 2-46-2-705, Kasuga Tsukuba-shi, Ibaraki 305-0821 / JP | 02 /
Emori, Eita 1-8-19-202, Namiki Tsuchiura-shi, Ibaraki 300-0061 / JP | 03 /
Matsuura, Fumiyoshi 3-25-2-205, Matsushiro Tsukuba-shi, Ibaraki 305-0035 / JP | 04 /
Clark, Richard 2-20-22, Ottominami Tsuchiura-shi, Ibaraki 300-0854 / JP | 05 /
Ikuta, Hironori 2-35-12, Sakae-cho Ushiku-shi, Ibaraki 300-1233 / JP | 06 /
Yasuda, Nobuyuki 820-1, Oaza Hitana Tsuchiura-shi, Ibaraki 300-0065 / JP | 07 /
Nagakura, Tadashi 2-39-1-3-406, Tagu Ushiku-shi, Ibaraki 300-1237 / JP | 08 /
Yamazaki, Kazuto 3-19-1-3-304, Azuma Tsukuba-shi, Ibaraki 305-0031 / JP | 09 /
Aoki, Mika 4679-1-206, Houjyo Tsukuba-shi, Ibaraki 300-4231 / JP | [2003/35] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
| Former [2005/04] | VOSSIUS & PARTNER Siebertstrasse 4 81675 München / DE | ||
| Former [2003/35] | Warcoin, Jacques, et al Cabinet Régimbeau 20, rue de Chazelles 75847 Paris cedex 17 / FR | Application number, filing date | 03290431.0 | 24.02.2003 | [2003/35] | Priority number, date | JP20020047761 | 25.02.2002 Original published format: JP 2002047761 | JP20020149557 | 23.05.2002 Original published format: JP 2002149557 | [2003/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1338595 | Date: | 27.08.2003 | Language: | EN | [2003/35] | Type: | A3 Search report | No.: | EP1338595 | Date: | 08.10.2003 | [2003/41] | Type: | B1 Patent specification | No.: | EP1338595 | Date: | 03.05.2006 | Language: | EN | [2006/18] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 26.08.2003 | Classification | IPC: | C07D473/06, C07D473/08 | [2003/35] | CPC: |
C07D473/06 (EP,US);
A61P3/10 (EP);
C07D473/08 (EP,US)
| Designated contracting states | DE, FR, GB [2004/27] |
| Former [2003/35] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR | Title | German: | Xanthin-Derivate als DPP-IV-Inhibitoren | [2003/35] | English: | Xanthine derivatives as DPP-IV inhibitors | [2003/35] | French: | Dérivés de Xanthines servant d'inhibiteurs de DPP-IV | [2003/35] | Examination procedure | 17.03.2003 | Examination requested [2003/35] | 10.09.2003 | Amendment by applicant (claims and/or description) | 21.09.2004 | Despatch of a communication from the examining division (Time limit: M06) | 24.03.2005 | Reply to a communication from the examining division | 11.04.2005 | Despatch of a communication from the examining division (Time limit: M06) | 25.08.2005 | Reply to a communication from the examining division | 27.09.2005 | Communication of intention to grant the patent | 03.02.2006 | Fee for grant paid | 03.02.2006 | Fee for publishing/printing paid | Opposition(s) | 06.02.2007 | No opposition filed within time limit [2007/15] | Fees paid | Renewal fee | 28.02.2005 | Renewal fee patent year 03 | 28.02.2006 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | FR | 03.05.2006 | DE | 04.08.2006 | [2009/01] |
| Former [2007/40] | DE | 04.08.2006 | Documents cited: | Search | [A]EP1054012 (EISAI CO LTD [JP]) [A] 1-32* claim 1 *; | [XY]WO0202560 (NOVO NORDISK AS [DK], et al) [X] 1-3,6-32 * page 2, line 22 - page 2, line 25; claims 1-3 * * page 2, line 22 - page 9, line 25; claims 1-3 * [Y] 1,4-32; | [PY]DE10109021 (BOEHRINGER INGELHEIM PHARMA [DE]) [PY] 1-32 * page 8, line 39 - page 9, line 48; claims 1,4 *; | [PY]DE10117803 (BOEHRINGER INGELHEIM PHARMA [DE]) [PY] 1-32 * claims 1,4,7 *; | [A] - AUGUSTYNS K ET AL, "THE UNIQUE PROPERTIES OF DIPEPTIDYL-PEPTIDASE IV (DPP IV/CD26) AND THE THERAPEUTIC POTENTIAL OF DPP IV INHIBITORS", CURRENT MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS BV, BE, (1999), vol. 6, no. 4, ISSN 0929-8673, pages 311 - 327, XP000870290 [A] 1-32 * paragraph "DPP IV Inhibitors", pages 314-317 * |